Itron, Inc. (NASDAQ:ITRI)‘s stock had its “outperform” rating restated by equities researchers at Oppenheimer Holdings, Inc. in a research note issued to investors on Friday, August 4th. They currently have a $78.00 target price on the scientific and technical instruments company’s stock, up from their prior target price of $75.00. Oppenheimer Holdings, Inc.’s target price points to a potential upside of 7.36% from the stock’s current price. Oppenheimer Holdings also issued estimates for Itron’s Q3 2017 earnings at $0.96 EPS, Q4 2017 earnings at $0.99 EPS, FY2017 earnings at $3.05 EPS, FY2019 earnings at $4.51 EPS and FY2020 earnings at $5.39 EPS.
Other equities analysts also recently issued reports about the company. Cowen and Company set a $60.00 target price on Itron and gave the company a “hold” rating in a research report on Friday, July 21st. Robert W. Baird reissued an “outperform” rating and issued a $73.00 target price on shares of Itron in a research report on Thursday, July 13th. BidaskClub downgraded Itron from a “strong-buy” rating to a “buy” rating in a research report on Thursday, July 27th. Guggenheim assumed coverage on Itron in a research report on Tuesday, June 20th. They issued a “buy” rating and a $81.00 target price on the stock. Finally, Canaccord Genuity reaffirmed a “buy” rating and issued a $72.00 price target on shares of Itron in a report on Friday, May 26th. Three analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company. Itron has an average rating of “Buy” and an average target price of $79.00.
Itron (NASDAQ:ITRI) traded down 0.55% during trading on Friday, hitting $72.65. The stock had a trading volume of 206,008 shares. Itron has a 52-week low of $47.20 and a 52-week high of $75.60. The firm has a market cap of $2.81 billion, a PE ratio of 89.91 and a beta of 1.10. The company’s 50 day moving average is $71.48 and its 200 day moving average is $65.89.
Itron (NASDAQ:ITRI) last released its earnings results on Wednesday, August 2nd. The scientific and technical instruments company reported $0.71 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.68 by $0.03. Itron had a return on equity of 15.43% and a net margin of 1.60%. The firm had revenue of $503.10 million for the quarter, compared to the consensus estimate of $491.80 million. During the same period in the prior year, the firm earned $0.65 EPS. The firm’s revenue was down 1.9% on a year-over-year basis. Equities research analysts forecast that Itron will post $3.07 earnings per share for the current year.
ILLEGAL ACTIVITY WARNING: “Itron, Inc. (NASDAQ:ITRI) Given Outperform Rating at Oppenheimer Holdings, Inc.” was originally posted by StockNewsTimes and is owned by of StockNewsTimes. If you are viewing this report on another publication, it was stolen and republished in violation of U.S. and international trademark & copyright laws. The correct version of this report can be read at https://stocknewstimes.com/2017/08/17/itron-inc-nasdaqitri-rating-reiterated-by-oppenheimer-holdings-inc-updated.html.
Several large investors have recently bought and sold shares of ITRI. PNC Financial Services Group Inc. raised its stake in Itron by 2.0% in the second quarter. PNC Financial Services Group Inc. now owns 1,610 shares of the scientific and technical instruments company’s stock valued at $109,000 after buying an additional 31 shares during the last quarter. Pacad Investment Ltd. raised its stake in Itron by 21.4% in the second quarter. Pacad Investment Ltd. now owns 1,700 shares of the scientific and technical instruments company’s stock valued at $115,000 after buying an additional 300 shares during the last quarter. LS Investment Advisors LLC raised its stake in Itron by 56.2% in the first quarter. LS Investment Advisors LLC now owns 1,892 shares of the scientific and technical instruments company’s stock valued at $115,000 after buying an additional 681 shares during the last quarter. Riverhead Capital Management LLC raised its stake in Itron by 74.8% in the second quarter. Riverhead Capital Management LLC now owns 2,097 shares of the scientific and technical instruments company’s stock valued at $142,000 after buying an additional 897 shares during the last quarter. Finally, SG Americas Securities LLC raised its stake in Itron by 1.5% in the first quarter. SG Americas Securities LLC now owns 2,366 shares of the scientific and technical instruments company’s stock valued at $144,000 after buying an additional 36 shares during the last quarter. 95.25% of the stock is currently owned by institutional investors and hedge funds.
Itron Company Profile
Itron, Inc (Itron) is a technology and service company. The Company provides solutions that measure, manage and analyze energy and water use. The Company operates through three segments: Electricity, Gas and Water. It provides a portfolio of products, solutions, software and services to electric, gas and water utility customers across the globe.
Receive News & Ratings for Itron Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Itron Inc. and related companies with MarketBeat.com's FREE daily email newsletter.
